These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34263573)

  • 1. [NUCLEAR MEDICINE AND MOLECULAR IMAGING: FROM BASIC SCIENCE TO THE FRONT IN INNOVATIVE IMAGING AND TREATMENT].
    Hod N; Levin D; Tiktinsky K; Ezroh Katzap D; Lantsberg S
    Harefuah; 2021 Jul; 160(7):448-454. PubMed ID: 34263573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [THE HISTORY OF NUCLEAR MEDICINE IN ISRAEL: FROM OCCULT MEDICINE TO AN ADVANCED MULTIDISCIPLINARY SPECIALTY].
    Zwas T
    Harefuah; 2021 Jul; 160(7):468-473. PubMed ID: 34263576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT.
    Slart RHJA; Williams MC; Juarez-Orozco LE; Rischpler C; Dweck MR; Glaudemans AWJM; Gimelli A; Georgoulias P; Gheysens O; Gaemperli O; Habib G; Hustinx R; Cosyns B; Verberne HJ; Hyafil F; Erba PA; Lubberink M; Slomka P; Išgum I; Visvikis D; Kolossváry M; Saraste A
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1399-1413. PubMed ID: 33864509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.
    Munley MT; Marks LB; Scarfone C; Sibley GS; Patz EF; Turkington TG; Jaszczak RJ; Gilland DR; Anscher MS; Coleman RE
    Lung Cancer; 1999 Feb; 23(2):105-14. PubMed ID: 10217614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose in nuclear medicine: the hybrid imaging.
    Salvatori M; Rizzo A; Rovera G; Indovina L; Schillaci O
    Radiol Med; 2019 Aug; 124(8):768-776. PubMed ID: 30771217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics: The Role of Quantitative Nuclear Medicine Imaging.
    Könik A; O'Donoghue JA; Wahl RL; Graham MM; Van den Abbeele AD
    Semin Radiat Oncol; 2021 Jan; 31(1):28-36. PubMed ID: 33246633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments and future trends in nuclear medicine instrumentation.
    Zaidi H
    Z Med Phys; 2006; 16(1):5-17. PubMed ID: 16696367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis: Nuclear Medicine state-of-the-art imaging.
    Rosado-de-Castro PH; Lopes de Souza SA; Alexandre D; Barbosa da Fonseca LM; Gutfilen B
    World J Orthop; 2014 Jul; 5(3):312-8. PubMed ID: 25035834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
    Xiao T; Li D; Shi X; Shen M
    Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
    Wagenaar DJ; Kapusta M; Li J; Patt BE
    Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New challenges and perspectives in nuclear medicine imaging].
    Borbély K
    Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective.
    Calabria F; Leporace M; Cimini A; Ricci M; Travascio L; Bagnato A
    J Integr Neurosci; 2023 Dec; 22(6):172. PubMed ID: 38176937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.